Holding(s) in Company

RNS Number : 7566Q
Dechra Pharmaceuticals PLC
17 April 2009
 




For filings with the FSA include the annex

For filings with issuer exclude the annex 


TR-1: Notifications of Major Interests in Shares


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Dechra Pharmaceuticals



2. Reason for notification (yes/no)


An acquisition or disposal of voting rights


yes


An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 



An event changing the breakdown of voting rights



Other (please specify):______________



3. Full name of person(s) subject to notification obligation:

Schroders plc


4. Full name of shareholder(s) (if different from 3):



5. Date of transaction (and date on which the threshold is crossed or reached if different):


16.04.09


6. Date on which issuer notified:


17.04.09


7. Threshold(s) that is/are crossed or reached:


From 13% - 14%



8: Notified Details

A: Voting rights attached to shares


Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights


Direct


Indirect


Direct


Indirect

Ordinary

GB0009633180


9,954,762


9,164,319


11,302,210


N/A


9,225,690


N/A


14.08%




B: Financial Instruments


Resulting situation after the triggering transaction


Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights









Total (A+B)


Number of voting rights

Percentage of voting rights


9,225,690


14.08%




9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:


Schroder Investment Management Limited                                  8,531,780           13.03%

 

Schroder Investment Management North America Limited         693,910               1.06%

 


Proxy Voting:


10. Name of proxy holder:



11. Number of voting rights proxy holder will cease to hold:



12. Date on which proxy holder will cease to hold voting rights:




13. Additional information:


The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements

14 Contact name:


Andrea Rowe

15. Contact telephone number:


020 7658 6000


For notes on how to complete form TR-1 please see the FSA website. 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLKGGMDGNGGLZM
UK 100

Latest directors dealings